NCT05617651View on ClinicalTrials.gov

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

December 10, 2024

Study Completion Date

December 30, 2025

Conditions
Pharmacokinetics
Interventions
DRUG

IY-NT-T

Ilaprazole 20mg

DRUG

IY-NT-R

Ilaprazole 10mg

Trial Locations (1)

08756

H plus Yangji Hospital, Seoul

All Listed Sponsors
lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY

NCT05617651 - Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T | Biotech Hunter | Biotech Hunter